Member Info for Escapetohome

Dead Meat !

Until a low ball takeover received. Management handsomely rewarded.

Never in human history has there been a management who failed to realise that the share price level is very important.

Who wouldn't want to legally sponge off others ?

Those with backbones.

End this sorry story.

I think it would detract from their own trials , people might say they they are losing focus.

Even worse , the pinkies and greenies, who believe the hype and vote yeah and stump up cash to allow it to continue.

I truly feel sorry for these folk, lubed and abused.

Don't be so sensitive, African countries are winning, and they are not bothered by banana republic terminology. They are confident .

So stop trying to hang a guilt trip on peps.

However good or bad it is, it deserves to be gobbled up at a super low price. Share price matters. Fix it.

DOWN.

Stick to enet, the current exploiter and enslaver of your hard earned!

History teaches us but that's it, no need to carry a cross on your back about it .

I don't know if any of you follow CARDIOGENI ( listed on aquis), a company spun out from Celixir , which also spun out Oncogeni , acquired by Roquefort . Both seemed dependent on middle east funding for part of their folio. Well I think Cardiogeni now got an alternative source of funding, other than the hoped for middle eastern. Well, also, I noticed Ajan sold his stake in Roquefort but he retains a large stake in cardiogeni and had a small top up as well. All the same I'm not recommending cardiogeni, and have a very small holding there.

As far as I can tell cardiogeni now owns a 32,5% stake in Lumen Longevity Clinics, in a share exchange with Kira Health Invest AG. It seems they have secured a funding to be paid in tranches to the tune of $25 million. This will allow them to progress their heart cell medicine CLXR-001.

Following that news Ajan had a top up, so I assume it is a positive.

I recently discovered that Celixir some years ago ran into trouble with the regulator over the conduct of trials. This is no longer relevant now though.

And at this price we all stand to do pretty well if they do, and if they continue to plod along we're ok thanks. There are many many worse.

So sit back and relax folks!

We can always hope. My guess is celea financing will help a little, but like all the other value accretive opportunities, will not enable escape velocity .

You didn't answer what the prefix patent does and why this would give an advantage to enet customers?

Just saying it's great and might bring in some customers is a huge gamble

After Dave's milked the last sheckel out of it.

Selling the next placing , a news update may accompany it.

One of the most disappointing shares in human history.

12k? Very very high.

And the celea funding isn't going to change it much.

The only thing that might bring out some value is a low ball bid.

The bod allow stealing✓

An absolute disaster. Shorts having a whale of a time.

This isn't going anywhere.

Dave's productivity in a full time job was zero, now it's 1\5 of zero.

AI stealth chip? For luring in the green pinkies.